NDAINJECTIONINJECTABLE
Approved
Dec 1977
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 23h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OSTEOLITE is a technetium Tc-99m labeled diagnostic kit used for skeletal scintigraphy to detect bone lesions, infections, and metabolic abnormalities. It is a radiopharmaceutical injectable that localizes in bone tissue to visualize skeletal pathology through gamma imaging. The product enables clinicians to assess bone metabolism and identify areas of increased osteogenic activity.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30%), indicating potential team contraction and focus on cost management.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OSTEOLITE offers stability in a mature diagnostic market but limited growth opportunity as the product approaches loss of exclusivity. Career advancement would require focus on operational excellence, market defense, and cost optimization rather than launch or expansion activities.
Diagnostic Product ManagerField Sales Representative
Worked on OSTEOLITE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.